CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

AKUMS DRUGS & PHARMACEUTICALS LTD.

NSE : AKUMSBSE : 544222ISIN CODE : INE09XN01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE668.1060.7 (+9.99 %)
PREV CLOSE () 607.40
OPEN PRICE () 619.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 133956
TODAY'S LOW / HIGH ()608.05 668.10
52 WK LOW / HIGH ()527 1174.85
NSE668.4060.75 (+10 %)
PREV CLOSE() 607.65
OPEN PRICE () 612.70
BID PRICE (QTY) 668.40 (77173)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2105937
TODAY'S LOW / HIGH() 608.05 668.40
52 WK LOW / HIGH ()530.05 1175.9
Managing DirectorSanjeev Jain
Sandeep Jain
Company SecretaryDharamvir Malik
Nominee DirectorSunil Kumar Thakur
Non Executive Independent DirectorKewal Kundanlal Handa
Matangi Gowrishankar
Nand Lal Kalra
Satwinder Singh
Whole Time DirectorSanjay Sinha
Incorporation Year : 19-04 2004

Registered Office :

Address : 304 Mohan Place, L S C ,Saraswati Vihar, Delhi,
Delhi-110034 .

Phone : 011- 69041000

Email :  cs@akums.net 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX78699.07226.59 (0.29%)
NIFTY23813.4063.20 (0.27%)
Dow Jones 42992.21-333.59 (-0.77%)
Nasdaq 19722.03-298.33 (-1.49%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI